Norikazu Ohtake
Taisho Pharmaceutical (Japan)(JP)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Synthesis of β-Lactam Compounds
Most-Cited Works
- → N- Acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: The first orexin-2 receptor selective non-peptidic antagonist(2003)114 cited
- → Design, Synthesis, and Discovery of a Novel CCR1 Antagonist(2001)89 cited
- → Dicationic dithiocarbamate carbapenems with anti-MRSA activity(2001)68 cited
- → Structure–activity relationships of xanthene carboxamides, novel CCR1 receptor antagonists(2003)67 cited
- → Discovery of a novel CCR3 selective antagonist(2001)66 cited
- → Lead Identification of 8-(Methylamino)-2-oxo-1,2-dihydroquinoline Derivatives as DNA Gyrase Inhibitors: Hit-to-Lead Generation Involving Thermodynamic Evaluation(2020)59 cited
- → J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors(1999)49 cited
- → A Potent, Long-Acting, Orally Active (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: A Novel Muscarinic M3 Receptor Antagonist with High Selectivity for M3 over M2 Receptors(2000)46 cited
- → Design, syntheses, and structure–activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4′-piperidin]-1′-yl}benzimidazole derivatives(2008)45 cited
- → Discovery and structure–activity relationships of a novel class of quinazoline glucokinase activators(2009)41 cited